{"id":1042,"date":"2015-07-02T17:41:02","date_gmt":"2015-07-02T15:41:02","guid":{"rendered":"https:\/\/www.lungcancergroup.de\/en\/project\/a-synergistic-interaction-between-chk1-and-mk2-inhibitors-in-kras-mutant-cancer\/"},"modified":"2016-03-07T15:19:05","modified_gmt":"2016-03-07T14:19:05","slug":"a-synergistic-interaction-between-chk1-and-mk2-inhibitors-in-kras-mutant-cancer","status":"publish","type":"project","link":"https:\/\/www.lungcancergroup.de\/en\/project\/a-synergistic-interaction-between-chk1-and-mk2-inhibitors-in-kras-mutant-cancer\/","title":{"rendered":"A Synergistic Interaction between Chk1- and MK2 Inhibitors in KRAS-Mutant Cancer."},"content":{"rendered":"<p>[et_pb_section admin_label=&#8221;section&#8221;][et_pb_row admin_label=&#8221;row&#8221;][et_pb_column type=&#8221;4_4&#8243;][et_pb_text admin_label=&#8221;Projekttitel&#8221; background_layout=&#8221;light&#8221; text_orientation=&#8221;left&#8221; text_font_size=&#8221;14&#8243; use_border_color=&#8221;off&#8221; border_color=&#8221;#ffffff&#8221; border_style=&#8221;solid&#8221;]<\/p>\n<h4><a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26140595\/\" target=\"_blank\">A Synergistic Interaction between Chk1- and MK2 Inhibitors in KRAS-Mutant Cancer. <\/a><\/h4>\n<p>[\/et_pb_text][et_pb_text admin_label=&#8221;Autoren&#8221; background_layout=&#8221;light&#8221; text_orientation=&#8221;left&#8221; text_font_size=&#8221;14&#8243; use_border_color=&#8221;off&#8221; border_color=&#8221;#ffffff&#8221; border_style=&#8221;solid&#8221;]<\/p>\n<p>Dietlein F, Kalb B, Jokic M, Noll EM, Strong A, Tharun L, Ozreti\u0107 L, K\u00fcnstlinger H, Kambartel K, Randerath WJ, J\u00fcngst C, Schmitt A, Torgovnick A, Richters A, Rauh D, Siedek F, Persigehl T, Mauch C, Bartkova J, Bradley A, Sprick MR, Trumpp A, Rad R, Saur D, Bartek J, Wolf J, B\u00fcttner R, Thomas RK, Reinhardt HC.<\/p>\n<p>[\/et_pb_text][et_pb_text admin_label=&#8221;Journal+Ver\u00f6ffentlichung&#8221; background_layout=&#8221;light&#8221; text_orientation=&#8221;left&#8221; use_border_color=&#8221;off&#8221; border_color=&#8221;#ffffff&#8221; border_style=&#8221;solid&#8221;]<\/p>\n<p>Journal: Cell<br \/>\nVer\u00f6ffentlichung: 2. Jul. 2015 (Epub\u00a02. Jul. 2015)<\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Journal: Cell<br \/>\npublished 2nd of july, 2015<\/p>\n","protected":false},"author":19,"featured_media":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"project_category":[40],"project_tag":[],"class_list":["post-1042","project","type-project","status-publish","hentry","project_category-2015-en"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.7 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>A Synergistic Interaction between Chk1- and MK2 Inhibitors in KRAS-Mutant Cancer. - Lung Cancer Group Cologne<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.lungcancergroup.de\/en\/project\/a-synergistic-interaction-between-chk1-and-mk2-inhibitors-in-kras-mutant-cancer\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"A Synergistic Interaction between Chk1- and MK2 Inhibitors in KRAS-Mutant Cancer. - Lung Cancer Group Cologne\" \/>\n<meta property=\"og:description\" content=\"Journal: Cell published 2nd of july, 2015\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.lungcancergroup.de\/en\/project\/a-synergistic-interaction-between-chk1-and-mk2-inhibitors-in-kras-mutant-cancer\/\" \/>\n<meta property=\"og:site_name\" content=\"Lung Cancer Group Cologne\" \/>\n<meta property=\"article:modified_time\" content=\"2016-03-07T14:19:05+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.lungcancergroup.de\/en\/project\/a-synergistic-interaction-between-chk1-and-mk2-inhibitors-in-kras-mutant-cancer\/\",\"url\":\"https:\/\/www.lungcancergroup.de\/en\/project\/a-synergistic-interaction-between-chk1-and-mk2-inhibitors-in-kras-mutant-cancer\/\",\"name\":\"A Synergistic Interaction between Chk1- and MK2 Inhibitors in KRAS-Mutant Cancer. - Lung Cancer Group Cologne\",\"isPartOf\":{\"@id\":\"https:\/\/www.lungcancergroup.de\/en\/#website\"},\"datePublished\":\"2015-07-02T15:41:02+00:00\",\"dateModified\":\"2016-03-07T14:19:05+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.lungcancergroup.de\/en\/project\/a-synergistic-interaction-between-chk1-and-mk2-inhibitors-in-kras-mutant-cancer\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.lungcancergroup.de\/en\/project\/a-synergistic-interaction-between-chk1-and-mk2-inhibitors-in-kras-mutant-cancer\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.lungcancergroup.de\/en\/project\/a-synergistic-interaction-between-chk1-and-mk2-inhibitors-in-kras-mutant-cancer\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\/\/www.lungcancergroup.de\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Projects\",\"item\":\"https:\/\/www.lungcancergroup.de\/en\/project\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"A Synergistic Interaction between Chk1- and MK2 Inhibitors in KRAS-Mutant Cancer.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.lungcancergroup.de\/en\/#website\",\"url\":\"https:\/\/www.lungcancergroup.de\/en\/\",\"name\":\"Lung Cancer Group Cologne\",\"description\":\"Lungenkrebs Studiengruppe K\u00f6ln\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.lungcancergroup.de\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"A Synergistic Interaction between Chk1- and MK2 Inhibitors in KRAS-Mutant Cancer. - Lung Cancer Group Cologne","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.lungcancergroup.de\/en\/project\/a-synergistic-interaction-between-chk1-and-mk2-inhibitors-in-kras-mutant-cancer\/","og_locale":"en_US","og_type":"article","og_title":"A Synergistic Interaction between Chk1- and MK2 Inhibitors in KRAS-Mutant Cancer. - Lung Cancer Group Cologne","og_description":"Journal: Cell published 2nd of july, 2015","og_url":"https:\/\/www.lungcancergroup.de\/en\/project\/a-synergistic-interaction-between-chk1-and-mk2-inhibitors-in-kras-mutant-cancer\/","og_site_name":"Lung Cancer Group Cologne","article_modified_time":"2016-03-07T14:19:05+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.lungcancergroup.de\/en\/project\/a-synergistic-interaction-between-chk1-and-mk2-inhibitors-in-kras-mutant-cancer\/","url":"https:\/\/www.lungcancergroup.de\/en\/project\/a-synergistic-interaction-between-chk1-and-mk2-inhibitors-in-kras-mutant-cancer\/","name":"A Synergistic Interaction between Chk1- and MK2 Inhibitors in KRAS-Mutant Cancer. - Lung Cancer Group Cologne","isPartOf":{"@id":"https:\/\/www.lungcancergroup.de\/en\/#website"},"datePublished":"2015-07-02T15:41:02+00:00","dateModified":"2016-03-07T14:19:05+00:00","breadcrumb":{"@id":"https:\/\/www.lungcancergroup.de\/en\/project\/a-synergistic-interaction-between-chk1-and-mk2-inhibitors-in-kras-mutant-cancer\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.lungcancergroup.de\/en\/project\/a-synergistic-interaction-between-chk1-and-mk2-inhibitors-in-kras-mutant-cancer\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.lungcancergroup.de\/en\/project\/a-synergistic-interaction-between-chk1-and-mk2-inhibitors-in-kras-mutant-cancer\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/www.lungcancergroup.de\/en\/"},{"@type":"ListItem","position":2,"name":"Projects","item":"https:\/\/www.lungcancergroup.de\/en\/project\/"},{"@type":"ListItem","position":3,"name":"A Synergistic Interaction between Chk1- and MK2 Inhibitors in KRAS-Mutant Cancer."}]},{"@type":"WebSite","@id":"https:\/\/www.lungcancergroup.de\/en\/#website","url":"https:\/\/www.lungcancergroup.de\/en\/","name":"Lung Cancer Group Cologne","description":"Lungenkrebs Studiengruppe K\u00f6ln","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.lungcancergroup.de\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/www.lungcancergroup.de\/en\/wp-json\/wp\/v2\/project\/1042","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.lungcancergroup.de\/en\/wp-json\/wp\/v2\/project"}],"about":[{"href":"https:\/\/www.lungcancergroup.de\/en\/wp-json\/wp\/v2\/types\/project"}],"author":[{"embeddable":true,"href":"https:\/\/www.lungcancergroup.de\/en\/wp-json\/wp\/v2\/users\/19"}],"replies":[{"embeddable":true,"href":"https:\/\/www.lungcancergroup.de\/en\/wp-json\/wp\/v2\/comments?post=1042"}],"version-history":[{"count":2,"href":"https:\/\/www.lungcancergroup.de\/en\/wp-json\/wp\/v2\/project\/1042\/revisions"}],"predecessor-version":[{"id":1278,"href":"https:\/\/www.lungcancergroup.de\/en\/wp-json\/wp\/v2\/project\/1042\/revisions\/1278"}],"wp:attachment":[{"href":"https:\/\/www.lungcancergroup.de\/en\/wp-json\/wp\/v2\/media?parent=1042"}],"wp:term":[{"taxonomy":"project_category","embeddable":true,"href":"https:\/\/www.lungcancergroup.de\/en\/wp-json\/wp\/v2\/project_category?post=1042"},{"taxonomy":"project_tag","embeddable":true,"href":"https:\/\/www.lungcancergroup.de\/en\/wp-json\/wp\/v2\/project_tag?post=1042"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}